Staphylococcal complement inhibitors: Biological functions, recognition of complement components, and potential therapeutic implications

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 221-236

  Geisbrecht, Brian V ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT INHIBITOR; EFB PROTEIN; EHP PROTEIN; UNCLASSIFIED DRUG; COMPLEMENT; IMMUNOLOGIC FACTOR;

ANTIGEN RECOGNITION; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; EXPERIMENTAL MODEL; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ANALYSIS; CHEMICAL STRUCTURE; GENETICS; IMMUNOLOGY; METABOLISM; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNOLOGIC FACTORS; MODELS, MOLECULAR; STAPHYLOCOCCUS;

EID: 58149334961     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_16     Document Type: Review

References (44)

1. Al-Shangiti, A.M., Naylor, C.E., Nair, S.P., Briggs, D.C., Henderson, B. and Chain, B.M. (2004) Structural relationships and cellular tropism of Staphylococcal supernantigenlike proteins. Infect. Immun. 72, 4261-4270
2. Bredius, R.G., Driedijk, P.C., Schouten, M.F., Weening, R.S. and Out, T.A. (1992) Compelment activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type B, and tetanus toxoid. Infect. Immun. 60, 4838-4847
3. Cedergren, L., Andersson, R., Jansson, B., Uhlen, M. and Nilsson, B. (1993) Mutational analysis of the interaction between Staphylococcal protein A and human IgG1. Protein Eng. 6, 441-448
4. Chavakis, T., Wiechmann, K., Preissner, K.T. and Herrmann, M. (2005) Staphylococcus aureus interactions with the endothelium: the role of bacterial "Secreteable Expanded Repertoire Adhesive Molecules"(SERAM) in disturbing host defense systems. Thromb. Haemost. 94, 278-285
5. Chavakis, T., Preissner, K.T. and Herrmann, M. (2007) The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol. 28, 408-418
6. Chen, H., Schuster, M.C., Sfyroera, G., Geisbrecht, B.V. and Lambris, J.D. (2008) Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation nand mass spectrometry. J. Am. Soc. Mass. Spectrom. 19, 55-65
7. Cunnion, K.M., Lee, J.C. and Frank, M.M. (2001) Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect. Immun. 69, 6796-6803
8. Cunnion, K.M., Hair, P.S. and Buescher, E. (2004) Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect. Immun. 72, 2858-2863
9. Cunnion, K.M., Buescher, E.S. and Hair, P.S. (2005) Serum complement factor I decreases Staphylococcus aureus phagocytosis. J. Lab. Clin. Med. 146, 279-286
10. de Haas, C.J., Veldkamp, K.E., Peschel, A., Weerkamp, F., van Wamel, W.J., Heezius, E.C., Poppelier, M.J., van Kessel, K.P. and van Strijp, J.A. (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199, 687-695
11. Foster, T.J. (2005) Immune evasion by Staphylococci. Nat. Rev. Microbiol. 3, 948-958
12. Frank, M.M. (2001) Annihilating host defense. Nat. Med. 7, 1285-1286
13. Geisbrecht, B.V., Hamaoka, B.Y., Perman, B., Zemla, A. and Leahy, D.J. (2005) The crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens. J. Biol. Chem. 280, 17243-17250
14. Gouda, H., Torigoe, H., Saito, A., Sato, M., Arata, Y. and Shimada, I. (1992) Threedimensional solution structure of the B domain of Staphylococcal protein A: comparisons of the solution and crystal structures. Biochemistry 31, 9665-9672
15. Gros, P., Milder, F.J. and Janssen, B.J.C. (2008) Complement driven by conformational changes. Nat. Rev. Immunol. 8, 48-58
16. Haas, P.J., de Haas, C.J., Poppelier, M.J., van Kessel, K.P., van Strijp, J.A., Dijkstra, K., Scheek, R.M., Fan, H., Kruijtzer, J.A., Liskamp, R.M. and Kemmink, J. (2005) The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. J. Mol. Biol. 353, 859-872
17. Hammel, M., Sfyroera, G., Pyrpassopoulos, S., Ricklin, D., Ramyar, K.X., Pop, M., Jin, Z., Lambris, J.D. and Geisbrecht, B.V. (2007a) Characterization of Ehp: a secreted complement inhibitory protein from Staphylococcus aureus. J. Biol. Chem. 202, 30051-30061
18. Hammel, M., Sfyroera, G., Ricklin, D., Magotti, P., Lambris, J.D. and Geisbrecht, B.V. (2007b) A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 8, 430-437
19. Janssen, B.J.C., Huizinga, E.G., Raaijmakers, H.C.A., Roos, A., Daha, M.R., Ekdahl-Nilsson, K., Nilsson, B. and Gros, P. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511
20. Janssen, B.J.C., Christodoulidou, A., McCarthy, A., Lambris, J.D. and Gros, P. (2006) Structure of C3b reveals conformational changes underlying complement activity. Nature 444, 213-216
21. Jongerius, I., Köhl, J., Pandey, M.K., Ruyken, M., van Kessel, K.P., van Strijp, J.A. and Rooijakkers, S.H. (2007) Staphylococcal complement evasion by various convertaseblocking molecules J. Exp. Med. 204, 2461-2471
22. Kawasaki, A., Takada, H., Kotani, S., Inai, S., Nagaki, K., Matsumoto, M., Yokogawa, K., Kawata, S., Kusumoto, S. and Shiba, T. (1987) Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides - studies on active components and structural requirements. Microbiol. Immunol. 31, 551-569
23. Lambris, J.D., Ricklin, D. and Geisbrecht, B.V. (2008) Complement evasion by human pathogens. Nat. Rev. Microbiol. 6, 132-142
24. Langley, R., Wines, B., WIlloughby, N., Basu, I., Proft, T. and Fraser, J.D. (2005) The Staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcaRI binding and serum killing of bacteria. J. Immunol. 174, 2926-2933
25. Lee, L.Y.L., Hook, M., Haviland, D., Wetsel, R.A., Yonter, E.O., Syribeys, P., Vernachio, J. and Brown, E.L. (2004a) Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190, 571-579
26. Lee, L.Y.L., Liang, X., Hook, M. and Brown, E.L. (2004b) Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J. Biol. Chem. 279, 50710-50716
27. Lowy, F.D. (1998) Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532
28. Morikis, D. and Lambris, J.D. (2005) Structure, Dynamics, Activity, and Function of Compstatin and Design of More Potent Analogs. Taylor and Francis, Boca Raton, FL
29. Nagar, B., Jones, R.G., Diefenbach, R.J., Isenman, D.E. and Rini, J.M. (1998) X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280, 1277-1281
30. Neth, O., Jack, D.L., Johnson, M., Klein, N.J. and Turner, M.W. (2002) Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J. Immunol. 169, 4430-4436
31. Nguyen, T., Ghebrehiwet, B. and Peerschke, E.I.B. (2000) Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a nove mechanism for Staphylococcal interactions with platelets. Infect. Immun. 68, 2061-2068
32. O'Riordan, K. and Lee, J.C. (2004) Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17, 218-234
33. Peterson, P.K., Kim, Y., Wilkinson, B.J., Schmeling, D., Michael, A.F. and Quie, P.G. (1978) Dichotomy between opsonization and serum complement activation by encapsulated Staphylococci. Infect. Immun. 20, 770-775
34. Postma, B., Poppelier, M.J., van Galen, J.C., Prossnitz, E.R., van Strijp, J.A., de Haas, C.J. and van Kessel, K.P. (2004) Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 172, 6994-7001
35. Postma, B., Kleibeuker, W., Poppelier, M.J., Boonstra, M., van Kessel, K.P., van Strijp, J.A. and de Haas, C.J. (2005) Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. J. Biol. Chem. 280, 2020-2027
36. Ricklin, D. and Lambris, J.D. (2007) Complement-targeted therapeutics. Nat. Biotechnol. 25, 1265-1275
37. Rooijakkers, S.H., Ruyken, M., Roos, A., Daha, M.R., Presanis, J.S., Sim, R.B., van Wamel, W.J., van Kessel, K.P. and van Strijp, J.A. (2005a) Immune evasion by a Staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6, 920-927
38. Rooijakkers, S.H., van Kessel, K.P. and van Strijp, J.A. (2005b) Staphylococcal innate immune evasion. Trends Microbiol. 13, 596-601
39. Rooijakkers, S.H.M., Milder, F.J., Bardoel, B.W., Ruyken, M., van Strijp, J.A.G. and Gros, P. (2007) Staphylococcal complement inhibitor: structure and active sites. J. Immunol. 179, 2989-2998
40. Sahu, A. and Lambris, J.D. (2001) Structure and biology of complement protein 3, a connecting link between innate and acquired immunity. Immunol. Rev. 180, 35-48
41. Verbrugh, H.A., van Dijk, W.C., Peters, R., van der Tol, M.E. and Verhoef, J. (1979) The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid, and protein A in the processes of complement activation and opsonization. Immunology 37, 615-621
42. Verbrugh, H.A., Peterson, P.K., Nguyen, B.-Y.T., Sisson, S.P. and Kim, Y. (1982) Opsonization of encapsulated Stapylococcus aureus: the role of specific antibody and complement. J. Immunol. 129, 1681-1687
43. Wilkinson, B.J., Kim, Y., Peterson, P.K., Quie, P.G. and Michael, A.F. (1978) Activation of complement by cell surface components of Staphylococcus aureus. Infect. Immun. 20, 388-392
44. Zhang, L., Jacobsson, K., Vasi, J., Lindberg, M. and Frykberg, L. (1998) A second IgGbinding protein in Staphylococcus aureus. Microbiology 144, 985-991